Certified by Founder Lodge
F-Prime Capital
United States - Cambridge, MA
INVESTOR
1 Disclosed Funding Rounds $112,000,000
164 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management f
| Company | Date | Round | Raised |
|---|---|---|---|
 Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
 Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
 Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
 Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
 RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
 Burro |
January, 10 ,2024 | Series B | $24,000,000 |
 Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
 Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
 Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
 T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
 Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
 Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
 Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
 SpectrumAi (USA) |
March, 17 ,2023 | Series A | $20,000,000 |
 Latchel |
July, 27 ,2022 | Series A | $16,700,000 |
 Canary Technologies |
June, 13 ,2024 | Series C | $50,000,000 |
 Ashby |
September, 13 ,2022 | Series B | $21,500,000 |
 Vendr |
June, 16 ,2022 | Series B | $150,000,000 |
| Ashby |
September, 13 ,2022 | Series B | $21,500,000 |
 Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
 Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
 Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
| Albert Invent |
June, 15 ,2023 | Seed | $7,500,000 |
 Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
 Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
 HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
 Neumora |
October, 17 ,2022 | Series B | $112,000,000 |
 Odaseva |
June, 28 ,2024 | Series C | $54,000,000 |
| Latchel |
July, 27 ,2022 | Series A | $16,700,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| Canary Technologies |
June, 13 ,2024 | Series C | $50,000,000 |
| Ashby |
September, 13 ,2022 | Series B | $21,500,000 |
| SpectrumAi (USA) |
March, 17 ,2023 | Series A | $20,000,000 |
 Dispatch(US) |
January, 12 ,2024 | Seed | $8,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
| Vendr |
June, 16 ,2022 | Series B | $150,000,000 |
| Vendr |
June, 16 ,2022 | Series B | $150,000,000 |
| Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Rippl |
October, 04 ,2024 | Series A | $23,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Shinobi Therapeutics |
December, 13 ,2023 | Series A | $51,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
 Toku (YC S21) |
March, 27 ,2023 | Seed | $7,150,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Neumora |
October, 17 ,2022 | Series B | $112,000,000 |
 Simon Data |
August, 09 ,2023 | Series D | $54,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Proximie |
August, 14 ,2022 | Series C | $80,000,000 |
| Odaseva |
June, 28 ,2024 | Series C | $54,000,000 |
| Odaseva |
June, 28 ,2024 | Series C | $54,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Dispatch(US) |
January, 12 ,2024 | Seed | $8,000,000 |
| Canary Technologies |
June, 13 ,2024 | Series C | $50,000,000 |
| Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
 Equip |
February, 16 ,2022 | Series B | $58,000,000 |
| Vendr |
June, 16 ,2022 | Series B | $150,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Dispatch(US) |
January, 12 ,2024 | Seed | $8,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| Teleo |
June, 09 ,2022 | Series A | $12,000,000 |
 SpectrumAi |
June, 02 ,2022 | Seed | $9,000,000.00 |
| Latchel |
July, 27 ,2022 | Series A | $16,700,000 |
| Shinobi Therapeutics |
December, 13 ,2023 | Series A | $51,000,000 |
| Shinobi Therapeutics |
December, 13 ,2023 | Series A | $51,000,000 |
| HiLabs |
March, 15 ,2024 | Series B | $39,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Toku (YC S21) |
March, 27 ,2023 | Seed | $7,150,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
 CHARM Therapeutics |
June, 09 ,2022 | Series A | $50,000,000 |
| Simon Data |
August, 09 ,2023 | Series D | $54,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
 Adcentrx Therapeutics |
April, 25 ,2023 | Series A | $38,000,000 |
| Odaseva |
June, 28 ,2024 | Series C | $54,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
 Hone |
September, 13 ,2022 | Series A | $30,000,000 |
| Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Equip |
February, 16 ,2022 | Series B | $58,000,000 |
| Equip |
February, 16 ,2022 | Series B | $58,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Vendr |
June, 16 ,2022 | Series B | $150,000,000 |
| SpectrumAi (USA) |
March, 17 ,2023 | Series A | $20,000,000 |
| Dispatch(US) |
January, 12 ,2024 | Seed | $8,000,000 |
| SpectrumAi |
June, 02 ,2022 | Seed | $9,000,000.00 |
 Canoe Intelligence |
July, 10 ,2024 | Series C | $36,000,000 |
| Shinobi Therapeutics |
December, 13 ,2023 | Series A | $51,000,000 |
| Latchel |
July, 27 ,2022 | Series A | $16,700,000 |
| Odaseva |
June, 28 ,2024 | Series C | $54,000,000 |
| Latchel |
July, 27 ,2022 | Series A | $16,700,000 |
 Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
| RightHand Robotics, Inc |
February, 23 ,2022 | Series C | $66,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| CHARM Therapeutics |
June, 09 ,2022 | Series A | $50,000,000 |
| CHARM Therapeutics |
June, 09 ,2022 | Series A | $50,000,000 |
| SpectrumAi |
June, 02 ,2022 | Seed | $9,000,000.00 |
| Doceree |
April, 07 ,2022 | Series A | $11,000,000 |
| Adcentrx Therapeutics |
April, 25 ,2023 | Series A | $38,000,000 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Hone |
September, 13 ,2022 | Series A | $30,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Equip |
February, 16 ,2022 | Series B | $58,000,000 |
 Shift Bioscience |
October, 16 ,2024 | Seed | $16,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| Vendr |
June, 16 ,2022 | Series B | $150,000,000 |
| SpectrumAi (USA) |
March, 17 ,2023 | Series A | $20,000,000 |
| Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
| Canoe Intelligence |
July, 10 ,2024 | Series C | $36,000,000 |
| Canoe Intelligence |
July, 10 ,2024 | Series C | $36,000,000 |
| Latchel |
July, 27 ,2022 | Series A | $16,700,000 |
| Shinobi Therapeutics |
December, 13 ,2023 | Series A | $51,000,000 |
| Canary Technologies |
June, 13 ,2024 | Series C | $50,000,000 |
| Odaseva |
June, 28 ,2024 | Series C | $54,000,000 |
| Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
| Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| CHARM Therapeutics |
June, 09 ,2022 | Series A | $50,000,000 |
| Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
| Mathison |
May, 13 ,2022 | Series A | $25,000,000 |
| SpectrumAi |
June, 02 ,2022 | Seed | $9,000,000.00 |
| Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
| Paradigm |
January, 30 ,2023 | Series A | $200,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Burro |
January, 10 ,2024 | Series B | $24,000,000 |
| Engrail Therapeutics |
March, 20 ,2024 | Series B | $157,000,000 |
| Equip |
February, 16 ,2022 | Series B | $58,000,000 |
| Shift Bioscience |
October, 16 ,2024 | Seed | $16,000,000 |
| T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
| Peptone |
June, 09 ,2022 | Unknown | $40,000,000 |
| Better Life Partners |
August, 30 ,2023 | Series B | $26,500,000 |
| SpectrumAi (USA) |
March, 17 ,2023 | Series A | $20,000,000 |
| Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
| Eleos Health |
April, 05 ,2022 | Series A | $20,000,000 |
| Ashby |
September, 13 ,2022 | Series B | $21,500,000 |
| Shinobi Therapeutics |
December, 13 ,2023 | Series A | $51,000,000 |
| Canoe Intelligence |
July, 10 ,2024 | Series C | $36,000,000 |
 Axoni |
April, 27 ,2023 | Unknown | $20,000,000 |
| Expressable |
February, 09 ,2022 | Series A | $15,000,000 |
| Canary Technologies |
June, 13 ,2024 | Series C | $50,000,000 |
| Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
